Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction.
The advent of quantitative proteomics opens new opportunities in biomedical and clinical research. Although quantitative proteomics methods based on stable isotope labeling are in general preferred for biomolecular research, biomarker discovery is a case example of a biomedical problem that may be better addressed by using label-free MS techniques. As a proof of concept of this paradigm, we report the use of label-free quantitative LC-MS to profile the urinary peptidome of kidney chronic allograft dysfunction (CAD). The aim was to identify predictive biomarkers that could be used to personalize immunosuppressive therapies for kidney transplant patients. We detected (by LC-M/MS) and quantified (by LC-MS) 6000 polypeptide ions in undigested urine specimens across 39 CAD patients and 32 control individuals. Although unsupervised hierarchical clustering differentiated between the groups when including all the identified peptides, specific peptides derived from uromodulin and kininogen were found to be significantly more abundant in control than in CAD patients and correctly identified the two groups. These peptides are therefore potential biomarkers that might be used for the diagnosis of CAD. In addition, ions at m/z 645.59 and m/z 642.61 were able to differentiate between patients with different forms of CAD with specificities and sensitivities of 90% in a training set and, significantly, of approximately 70% in an independent validation set of samples. Interestingly low expression of uromodulin at m/z 638.03 coupled with high expression of m/z 642.61 diagnosed CAD in virtually all cases. Multiple reaction monitoring experiments further validated the results, illustrating the power of our label-free quantitative LC-MS approach for obtaining quantitative profiles of urinary polypeptides in a rapid, comprehensive, and precise fashion and for biomarker discovery.
Servicio de Nefrología y Trasplante renal, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universidad de Barcelona, Barcelona, Spain.
Luis F
LF
Quintana
Josep M
JM
Campistol
Maria P
MP
Alcolea
Elisenda
E
Bañon-Maneus
Amandaé
A
Sol-González
Pedro R
PR
Cutillas
D000328:Adult; D000368:Aged; D000595:Amino Acid Sequence; D015415:Biomarkers / Q000652:urine*; D002853:Chromatography, Liquid / Q000379:methods; D016000:Cluster Analysis; D005260:Female; D006801:Humans; D007668:Kidney / Q000737:chemistry / Q000378:metabolism; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry / Q000652:urine; D010641:Phenotype; D055031:Primary Graft Dysfunction / Q000175:diagnosis* / Q000628:therapy / Q000652:urine*; D040901:Proteomics / Q000379:methods*; D015203:Reproducibility of Results; D053719:Tandem Mass Spectrometry / Q000379:methods; D014184:Transplantation, Homologous
D015415:Biomarkers; D010455:Peptides